Back to search
Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase I, single-center, open-label, parallel-group study. A single oral dose of MDR-001, a GLP-1 receptor agonist, will be administered to participant…
Phase I Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury
This is a single-dose, open-label, phase I clinical study evaluating the PK of hetrombopag in subjects with mild hepatic impairment (Child-Pugh Class A), subjec…